what are glp-1 medications used for Infographic The Rise of GLP-1 Medications

2.4 Outcomes assessed The primary outcome was the incidence of any gastrointestinal (GI) cancer, including pancreatic, colorectal, gastric, and liver cancers

It acts pro-angiogenically via VEGFR2: the peptide promotes VEGFR2 internalization and activates the VEGFR2-Akt-eNOS pathway, which is blocked by the endocytosis inhibitor Dynasore, and in preclinical models it increased vessel density as well as the restoration of blood flow in the ischemic rat hindlimb Hsieh et al., 2017

Future studies using chronic or aged animal models will be essential to evaluate prolonged efficacy, dose tolerance, and systemic safety, including potential effects on organ function and histopathology

Total Fat